Literature DB >> 22778862

Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis.

Morteza Mahmoudi1, Mohammad A Sahraian, Mohammad A Shokrgozar, Sophie Laurent.   

Abstract

Smart superparamagnetic iron oxide nanoparticles (SPIONs) are the most promising candidate for theragnosis (i.e., diagnosis and treatment) of multiple sclerosis. A deep understanding of the dynamics of the in vivo neuropathology of multiple sclerosis can be achieved by improving the efficiency of various medical techniques (e.g., positron emission tomography and magnetic resonance imaging) using multimodal SPIONs. In this Review, recent advances and challenges in the development of smart SPIONs for theragnostic applications are comprehensively described. In addition, critical outlines of emerging developments are provided from the points of view of both clinicians and nanotechnologists.

Entities:  

Keywords:  Superparamagnetic iron oxide nanoparticles; multimodality; multiple sclerosis; neuropathology; theragnosis

Mesh:

Substances:

Year:  2011        PMID: 22778862      PMCID: PMC3369738          DOI: 10.1021/cn100100e

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  150 in total

1.  Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-12-01       Impact factor: 15.470

2.  Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients.

Authors:  Norbert Nighoghossian; Marlène Wiart; Serkan Cakmak; Yves Berthezène; Laurent Derex; Tae-Hee Cho; Chantal Nemoz; François Chapuis; Guy-Louis Tisserand; Jean-Baptiste Pialat; Paul Trouillas; Jean-Claude Froment; Marc Hermier
Journal:  Stroke       Date:  2006-12-14       Impact factor: 7.914

3.  Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: Genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells.

Authors:  Eric K Dufour; Tirukalikundram Kumaravel; Gerhard J Nohynek; David Kirkland; Hervé Toutain
Journal:  Mutat Res       Date:  2006-06-21       Impact factor: 2.433

4.  Generation of magnetic nonviral gene transfer agents and magnetofection in vitro.

Authors:  Olga Mykhaylyk; Yolanda Sánchez Antequera; Dialekti Vlaskou; Christian Plank
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 5.  Brain imaging of multiple sclerosis: the next 10 years.

Authors:  Paul M Matthews
Journal:  Neuroimaging Clin N Am       Date:  2009-02       Impact factor: 2.264

6.  Detection of hepatic metastases by superparamagnetic iron oxide-enhanced MR imaging: prospective comparison between 1.5-T and 3.0-T images in the same patients.

Authors:  Keitaro Sofue; Masakatsu Tsurusaki; Mototaka Miyake; Aine Sakurada; Yasuaki Arai; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2010-04-29       Impact factor: 5.315

Review 7.  Glycoconjugate probes and targets for molecular imaging using magnetic resonance.

Authors:  Carlos F G C Geraldes; Kristina Djanashvili; Joop A Peters
Journal:  Future Med Chem       Date:  2010-03       Impact factor: 3.808

8.  Controlled clustering of superparamagnetic nanoparticles using block copolymers: design of new contrast agents for magnetic resonance imaging.

Authors:  Jean-François Berret; Nicolas Schonbeck; Florence Gazeau; Delphine El Kharrat; Olivier Sandre; Annie Vacher; Marc Airiau
Journal:  J Am Chem Soc       Date:  2006-02-08       Impact factor: 15.419

9.  In vivo imaging of the aneurysm wall with MRI and a macrophage-specific contrast agent.

Authors:  Maarten Truijers; Jurgen J Fütterer; Satoru Takahashi; Roel A Heesakkers; Jan D Blankensteijn; Jelle O Barentsz
Journal:  AJR Am J Roentgenol       Date:  2009-11       Impact factor: 3.959

10.  Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis.

Authors:  Cornelia Laule; Irene M Vavasour; Kenneth P Whittall; Joel Oger; Donald W Paty; David K B Li; Alex L MacKay; Douglas L Arnold
Journal:  J Neurol       Date:  2003-08       Impact factor: 4.849

View more
  21 in total

Review 1.  Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.

Authors:  Houshang Amiri; Kolsoum Saeidi; Parvin Borhani; Arash Manafirad; Mahdi Ghavami; Valerio Zerbi
Journal:  ACS Chem Neurosci       Date:  2013-09-26       Impact factor: 4.418

2.  Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.

Authors:  Sophie Laurent; Morteza Mahmoudi
Journal:  Int J Mol Epidemiol Genet       Date:  2011-11-25

Review 3.  Toxicity of nanomaterials.

Authors:  Shahriar Sharifi; Shahed Behzadi; Sophie Laurent; M Laird Forrest; Pieter Stroeve; Morteza Mahmoudi
Journal:  Chem Soc Rev       Date:  2011-12-14       Impact factor: 54.564

4.  Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution.

Authors:  Morteza Mahmoudi; Fiona Quinlan-Pluck; Marco P Monopoli; Sara Sheibani; Hojatollah Vali; Kenneth A Dawson; Iseult Lynch
Journal:  ACS Chem Neurosci       Date:  2013-01-23       Impact factor: 4.418

Review 5.  Biodegradable calcium phosphate nanoparticles for cancer therapy.

Authors:  Razieh Khalifehzadeh; Hamed Arami
Journal:  Adv Colloid Interface Sci       Date:  2020-04-10       Impact factor: 12.984

6.  Magneto-Plasmonic Nanoparticle Grid Biosensor with Enhanced Raman Scattering and Electrochemical Transduction for the Development of Nanocarriers for Targeted Delivery of Protected Anticancer Drugs.

Authors:  Hoda Ilkhani; Chuan-Jian Zhong; Maria Hepel
Journal:  Nanomaterials (Basel)       Date:  2021-05-18       Impact factor: 5.076

7.  Merging worlds of nanomaterials and biological environment: factors governing protein corona formation on nanoparticles and its biological consequences.

Authors:  Parisa Foroozandeh; Azlan Abdul Aziz
Journal:  Nanoscale Res Lett       Date:  2015-05-16       Impact factor: 4.703

Review 8.  Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.

Authors:  Sumit Arora
Journal:  Int J Nanomedicine       Date:  2012-07-06

9.  Biocompatibility of crystalline opal nanoparticles.

Authors:  Marlen Hernández-Ortiz; Laura S Acosta-Torres; Genoveva Hernández-Padrón; Alicia I Mendieta; Rodolfo Bernal; Catalina Cruz-Vázquez; Victor M Castaño
Journal:  Biomed Eng Online       Date:  2012-10-22       Impact factor: 2.819

Review 10.  Nanostructures: a platform for brain repair and augmentation.

Authors:  Ruxandra Vidu; Masoud Rahman; Morteza Mahmoudi; Marius Enachescu; Teodor D Poteca; Ioan Opris
Journal:  Front Syst Neurosci       Date:  2014-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.